Detection of p53 gene mutation by rapid PCR‐SSCP and its association with poor survival in breast cancer

No abstract is available for this paper.

• Publication year

  1997

• Venue

  International Journal of Cancer

• Publication date

  1997-12-19

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/(SICI)1097-0215(19971219)74:6<642::AID-IJC15>3.0.CO;2-7PMID 9421363
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Prognostic significance of p53 gene alterations in node-negative breast cancer

  2004cited by this paper
• Do we really need prognostic factors for breast cancer?

  2004cited by this paper
• The clinical significance of p53 aberrations in human tumours

  2004cited by this paper
• Expert Commentary.

  2002cited by this paper
• A rapid and nonisotopic method for the screening and sequencing of p53 gene mutations in formalin-fixed, paraffin-embedded tumors.

  1997cited by this paper
• Assessing p53 status in breast cancer prognosis: where should you put the thermometer if you think your p53 is sick?

  1996cited by this paper
• Mutation detection by highly sensitive methods indicates that p53 gene mutations in breast cancer can have important prognostic value.

  1996cited by this paper
• p53 and Breast Cancer

  1996cited by this paper
• Relationship between p53 gene abnormalities and other tumour characteristics in breast‐cancer prognosis

  1996cited by this paper
• Prognostic factors in primary breast carcinoma.

  1995cited by this paper
• Complete sequencing of the p53 gene provides prognostic information in breast cancer patients, particularly in relation to adjuvant systemic therapy and radiotherapy

  1995cited by this paper
• TP53 mutations and abnormal p53 protein staining in breast carcinomas related to prognosis.

  1995cited by this paper
• Racial disparity in the association of p53 gene alterations with breast cancer survival.

  1995cited by this paper
• Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis.

  1994cited by this paper
• Relative efficiency of denaturing gradient gel electrophoresis and single strand conformation polymorphism in the detection of mutations in exons 5 to 8 of the p53 gene.

  1994cited by this paper
• p53 status and the efficacy of cancer therapy in vivo.

  1994cited by this paper
• P53 gene mutations and steroid receptor status in breast cancer. Clinicopathologic correlations and prognostic assessment

  1994cited by this paper
• Prognostic significance of TP53 alterations in breast carcinoma.

  1993cited by this paper
• C‐ErbB‐2 Amplification And Overexpression In Breast Cancer: Evaluation and Comparison of Southern Blot, Slot Blot, ELISA and Immunohistochemistry

  1993cited by this paper
• How sensitive is PCR‐SSCP?

  1993cited by this paper
• Cancer. p53, guardian of the genome.

  1992cited by this paper
• P53 in tumour pathology: Can we trust immunocytochemistry?

  1992cited by this paper
• p53, guardian of the genome

  1992cited by this paper
• pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long‐term follow‐up

  1991cited by this paper
• Diagnostic Histopathology of the Breast

  1988cited by this paper

• Screening and computational analysis of colorectal associated non-synonymous polymorphism in CTNNB1 gene in Pakistani population

  2019cites this paper
• Mutational analysis of p53 gene in sporadic breast carcinoma

  2015cites this paper
• Rapid detection of genetic mutations in individual breast cancer patients by next-generation DNA sequencing

  2015cites this paper
• Identification of p53 and Its Isoforms in Human Breast Carcinoma Cells

  2014cites this paper
• Only Missense Mutations Affecting the DNA Binding Domain of P53 Influence Outcomes in Patients with Breast Carcinoma

  2013cites this paper
• Minute virus of mice (MVMp) infection and NS1 expression induce p53 independent apoptosis in transformed rat fibroblast cells.

  2011cites this paper
• Molecular markers in breast carcinoma. A study with focus on molecular phenotypes, angiogenesis and stem cells in an African population

  2010cites this paper
• Mouse mammary tumor virus‐like env sequences in human breast cancer

  2008cites this paper
• Mouse mammary tumor virus: a cause of breast cancer in humans?

  2008cites this paper
• High‐throughput amplicon scanning of the TP53 gene in breast cancer using high‐resolution fluorescent melting curve analyses and automatic mutation calling

  2008cites this paper
• p53 and disease: when the guardian angel fails

  2006cites this paper
• Novel P53 mutations detected by FAMA in colorectal cancers.

  2006cites this paper
• DNA hypermethylation in breast cancer and its association with clinicopathological features.

  2006influential citation
• Germ-line variants in methyl-group metabolism genes and susceptibility to DNA methylation in human breast cancer.

  2006cites this paper
• TP53 mutations are associated with a particular pattern of genomic imbalances in breast carcinomas

  2005cites this paper
• p53 Codon 72 Polymorphism Predicts the Pathologic Response to Neoadjuvant Chemotherapy in Patients with Breast Cancer

  2005cites this paper
• Identification of human papillomavirus DNA gene sequences in human breast cancer

  2005influential citation
• Tumor suppressor genes in breast cancer: the gatekeepers and the caretakers.

  2005cites this paper
• Genetic polymorphisms in the MMP-2 and MMP-9 genes and breast cancer phenotype

  2004cites this paper
• The −174 G/C gene polymorphism in interleukin-6 is associated with an aggressive breast cancer phenotype

  2004cites this paper
• Chromosomal comparative genomic hybridization abnormalities in early- and late-onset human breast cancers: correlation with disease progression and TP53 mutations.

  2004cites this paper
• High frequency of G/C transversion on p53 gene alterations in breast cancers from Taiwan.

  2004cites this paper
• Prognostic and predictive value of p53 and p21 in breast cancer

  2004cites this paper
• Mouse Mammary Tumor-Like Virus Is Associated with p53 Nuclear Accumulation and Progesterone Receptor Positivity but not Estrogen Positivity in Human Female Breast Cancer

  2004cites this paper
• Breast cancer biomarkers and molecular medicine: part II

  2004cites this paper
• Methylenetetrahydrofolate reductase and thymidylate synthase polymorphisms are not associated with breast cancer risk or phenotype.

  2004cites this paper
• Mouse Mammary Tumor-Like Virus Is Associated with p 53 Nuclear Accumulation and Progesterone Receptor Positivity but not Estrogen Positivity in Human Female Breast Cancer

  2004cites this paper
• Correlations of breast carcinoma biomarkers and p53 tested by FASAY and immunohistochemistry.

  2003cites this paper
• Breast cancer biomarkers and molecular medicine

  2003cites this paper
• TP53 and breast cancer

  2003cites this paper
• Prognostic value of p 53 molecular status in high-risk primary breast cancer

  2003cites this paper
• TP 53 and Breast Cancer

  2003cites this paper
• Prognostic value of p53 molecular status in high-risk primary breast cancer.

  2003cites this paper
• Luteinizing hormone signaling and breast cancer: polymorphisms and age of onset.

  2003cites this paper
• Lack of association between CCND1 G870A polymorphism and the risk of breast and colorectal cancers.

  2003cites this paper
• Real-time PCR technology for cancer diagnostics.

  2002cites this paper
• Associations between common polymorphisms in TP53 and p21WAF1/Cip1 and phenotypic features of breast cancer.

  2002cites this paper
• Clonal heterogeneity of p53 mutations in ovarian cancer.

  2001cites this paper
• Prognostic value of TP53 gene mutation in adjuvant treated breast cancer patients

  2001cites this paper
• Clinical Relevance of T1-S, an Oncogene-Inducible, Secreted Glycoprotein of the Immunoglobulin Superfamily, in Node-Negative Breast Cancer

  2001cites this paper
• P53 determination alongside classical prognostic factors in node-negative breast cancer: an evaluation at more than 10-year follow-up.

  2000cites this paper
• p53 Gene Mutation, Microsatellite Instability and Adjuvant Chemotherapy: Impact on Survival of 388 Patients with Dukes’ C Colon Carcinoma

  2000cites this paper
• Relating genotype and phenotype in breast cancer: an analysis of the prognostic significance of amplification at eight different genes or loci and of p53 mutations.

  2000cites this paper
• Tumor-associated overexpression of the soluble T1-S receptor in lymph node-negative breast cancer.

  2000cites this paper
• Detecting p53 gene mutation of breast cancer and defining differences between silver staining PCR-SSCP and immunohistochemical staining.

  2000cites this paper
• A prospective trial of midwest breast cancer patients: A p53 gene mutation is the most important predictor of adverse outcome

  2000cites this paper
• Prognostic significance of TP53 gene mutation in 995 cases of colorectal carcinoma. Influence of tumour site, stage, adjuvant chemotherapy and type of mutation.

  2000cites this paper
• Prognostic significance of mutations to different structural and functional regions of the p53 gene in breast cancer.

  2000cites this paper
• Correlation of p53 Mutations in ThinPrep-Processed Fine Needle Breast Aspirates with Surgically Resected Breast Cancers

  2000cites this paper
• Routine analysis of p53 mutation in clinical breast tumor specimens using fluorescence-based polymerase chain reaction and single strand conformation polymorphism.

  2000cites this paper
• Radiosensitivity of human breast cancer cells transduced with wild-type p53 gene is influenced by the p53 status of parental cells.

  2000cites this paper
• Cellular kinetics and expression of bcl-2 and p53 in ductal carcinoma of the breast.

  2000cites this paper
• Molecular genetics and the assessment of human cancers

  1999cites this paper
• Genetik des Mammacarcinoms

  1999cites this paper
• Somatic mutations in the p53 gene and prognosis in breast cancer: a meta-analysis

  1999influential citation
• Molecular abnormalities associated with secretory carcinomas of the breast.

  1999cites this paper
• p53 status in breast carcinomas revealed by FASAY correlates well with p53 protein accumulation determined by immunohistochemistry.

  1999cites this paper
• TP53 gene mutation status in pretreatment biopsies of oesophageal adenocarcinoma has no prognostic value.

  1999cites this paper
• P53 alterations have no prognostic or predictive significance in Dukes' C rectal carcinomas.

  1999cites this paper
• p53 protein overexpression and gene mutation in mixed Müllerian tumors of the uterus.

  1999cites this paper
• Prognostic variables in node-negative and node-positive breast cancer

  1998influential citation
• Analysis of p53 gene mutation by polymerase chain reaction-single strand conformation polymorphism provides independent prognostic information in node-negative breast cancer.

  1998cites this paper
• [Molecular cell biology--basis for new diagnostic and therapeutic approaches in surgical oncology].

  1998cites this paper